A phase II study of hyper-CVAD with blinatumomab (blina) and inotuzumab ozogamicin (INO) for newly diagnosed Philadelphia chromosome (Ph)–negative B-cell acute lymphoblastic leukemia (ALL).
Join us to discover how Optical Genome Mapping (OGM) can help you in the characterization of complex samples. OGM is a non-sequencing technique that provides a high-resolution view of intact, long DNA ...
SAN DIEGO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics (NASDAQ: BNGO) participated in the Association for Molecular Pathology (AMP) Annual Meeting, held November 11-15, 2025 in Boston, MA. Key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results